Cann Group Limited announced that it has executed an employment agreement to formally appoint Ms. Jenni Pilcher to the role of CEO & Managing Director. Jenni joined Cann as a Non-executive Director on 15 September 2020. In February 2024, Jenni stepped into an Executive Director role to provide financial oversight of the Company, transitioning to Interim CEO following the notice of resignation of the CEO on 21 March 2024.

Jenni has over 15 years of senior finance executive experience in the medical, biotechnology and technology sectors, within small-mid cap ASX-listed companies. In addition to financial management, investor relations and corporate governance experience, Jenni has successfully completed multiple capital raisings and M&A transactions, including company acquisitions, asset sales, and a takeover defense. Most recently, Jenni was Chief Financial Officer & Company Secretary of technology communications company Whispir Ltd, and prior to that was CFO & Company Secretary of digital imaging company, Mach7 Technologies.

She has also previously held CFO roles with Australia biotechnology companies Alchemia Limited and Mesoblast Limited. Jenni is a member of Chartered Accountants Australia & New Zealand, a Graduate of the Governance Institute of Australia, and has a Bachelor of Business Studies (majoring in accounting) from Massey University in New Zealand. Ms Pilcher will be appointed for a fixed term ending on 1 July 2025, subject to termination by either party.

The fixed term can be extended at any time by mutual agreement, in writing, between Ms Pilcher and the Company.